CommercialCoverageMedium impact
Genetic Cancer Susceptibility Panels Using Next Generation Sequencing
Blue Cross & Blue Shield of Mississippi·MS · Oncology, OB-GYN, Gastroenterology +2 more·Medical Policy
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield Mississippi has updated their medical policy for genetic cancer susceptibility panels using next-generation sequencing (NGS). This policy defines coverage criteria and clinical guidelines for multi-gene cancer testing panels that can detect hereditary cancer syndromes across various cancer types including breast, ovarian, colorectal, and other hereditary cancers.
Action Required
Review the updated policy A.2.04.93 for genetic cancer susceptibility panels using NGS technology. Billing team should familiarize themselves with the covered genetic variants and associated cancer syndromes (BRCA1/2, Lynch syndrome genes, APC, PTEN, TP53, etc.) to ensure proper documentation supports medical necessity for genetic testing claims. Coordinate with providers to ensure genetic counseling and family history documentation meets policy requirements.